Schifano F
Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Health, Medicine and Life Sciences, University of Hertfordshire, AL10 9AB, Hertfordshire, UK. Electronic address: f.schifano@herts.ac.uk.
ArticleKetamine
Treatment and management approaches for ketamine misuse: A systematic review of medical interventions.
ArticleMDMA
Psychoactive Synthetic Adulterants in Tablets Sold as MDMA after the COVID-19 Pandemic: Implications for Central Effects.
ArticlePsychedelics
Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and "Smart Drug" Use and Misuse.
ArticleMDMA
Drugs Used in "Chemsex"/Sexualized Drug Behaviour-Overview of the Related Clinical Psychopharmacological Issues.
ArticleKetamine
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective.
ArticleKetamine
Stimulant and hallucinogenic novel psychoactive substances; an update.
ArticlePsilocybin
Psilocybin for Depression: From Credibility to Feasibility, What's Missing?
ArticlePsychedelics
The Benzydamine Experience: A Systematic Review of Benzydamine Abuse.
ArticlePsychedelics
COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis.
ArticleKetamine
Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997-2019.
ArticlePsychedelics
Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach.
ArticlePsychedelics
Psychedelic Fauna for Psychonaut Hunters: A Mini-Review.
ArticlePsilocybin
The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.
ArticlePsychedelics
Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?
ArticlePsychedelics